The findings of the present study demonstrated that moderate amounts of HAS could significantly reduce serum GSP and GHb levels and increase INS levels in IR model mice, thereby helping to alleviate lipid metabolic disorders, oxidative stress injury, and inflammation. Here, GNAS is linked to Disorder of lipid metabolism.